clopidogrel bisulfate

This page contains recent news articles, when available, and an overview of clopidogrel bisulfate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

First Launch Of Efient Worldwide Takes Place In The UK  -  ‎Apr 8, 2009‎
In this study, Efient® compared with clopidogrel bisulfate provided a 19% reduction in the primary composite endpoint of CVD, MI, or stroke (ARR - 2.2%; PharmaLive.com (press release)

Google-Sponsored Links Become DDMAC Enforcement Target  -  ‎Apr 8, 2009‎
For example, Sanofi-Aventis was cited for sponsored links featuring its blood-thinner Plavix (clopidogrel bisulfate) because it failed to use the required FDA news (subscription)

Plavix reduced major vascular events by 11% in heart disease  -  ‎Mar 31, 2009‎
...taking Plavix® (clopidogrel bisulfate) in addition to aspirin significantly reduced major vascular events by 11% over aspirin alone, at a median of 3.6 Health Newstrack

Thailand Pharmaceuticals and Healthcare Report Q2 2009 ...  -  ‎Apr 15, 2009‎
The generic product is much cheaper than its patented alternative, Sanofi-Aventis' Plavix (clopidogrel bisulfate), which had raised doubt about its efficacy PR-Inside.com (Pressemitteilung)

10-K: BRISTOL MYERS SQUIBB CO  -  ‎Feb 20, 2009‎
PLAVIX* (clopidogrel bisulfate) and ABILIFY* continue to drive worldwide sales growth with sales increases of 18% and 30%, respectively. MarketWatch (press release)

Possible Suitors in Big Pharma M&A  -  ‎Feb 27, 2009‎
Some point to Bristol-Myers Squibb, who faces near-term patent expiry on one of its top-selling drugs, “Plavix�? (clopidogrel bisulfate) as a possible Pharmaceutical Technology Magazine

美国心血管用�?�市场表现优异新�?��?�与竞争  -  ‎Mar 2, 2009‎
...由百时美施贵�?和赛诺�?�安万特公�?�销售的�?�物波立维（clopidogrel bisulfate）也被用�?�防止心�?病�?�作和中风，其以39亿美元的销售�?排在第4�?。2007年，在最畅销的治疗中国医药网

FDA: Early communication issued about safety of clopidogrel bisulfate  -  Jan 27, 2009
The FDA announced it is conducting an ongoing safety review of clopidogrel bisulfate after receiving reports that the pro-drug, which is metabolized in the HemOncToday,

New Questions About Plavix  -  Feb 2, 2009
Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix). available at: About - News & Issues,

Plavix sales help thicken BMS’s profits  -  Jan 29, 2009
Bristol-Myers Squibb swung into a healthy fourth-quarter profit with strong sales of Plavix (clopidogrel bisulfate). The blood thinner had worldwide sales Scrip World Pharmaceutical News (subscription),

Major Gains in Personalized Medicine Are Expected in 2009; More Rx ...  -  Feb 3, 2009
For example, the FDA is considering a label change for the anti-blood clotting drug Plavix (clopidogrel bisulfate). The requested change is based on recent Atlantic Information Services, Inc.,

Plavix with acid-lowering drugs increase risk of heart attack ...  -  Jan 29, 2009
By Mika Abad Toronto, January 29: Taking blood thinning drug, Plavix (Clopidogrel bisulfate) in combination with proton pump inhibitor drug increases the TheMedGuru,

What’s Going Around? Bronchitis And Nosebleeds  -  Jan 15, 2009
Do not take any medications that will thin the blood such as: aspirin, ibuprofen, clopidogrel bisulfate (Plavix), warfarin (Coumadin), fish oils, Vitamin E, WKRG-TV,

FDA de EEUU busca más información sobre anticoagulante Plavix  -  Jan 26, 2009
WASHINGTON (Reuters) - Los reguladores de salud de Estados Unidos informaron el lunes que están revisando la efectividad del anticoagulante de amplio uso Buena Salud

Court Declares That Plavix Patent Is Teflon  -  Dec 16, 2008
Sanofi sued after Apotex filed an Abbreviated New Drug Application (ANDA) for FDA approval to sell clopidogrel bisulfate, along with a paragraph IV Patent Baristas,

Sanofi wins ruling over Plavix in Apotex fight  -  Dec 12, 2008
District Court for the Southern District of New York that said Sanofi's patent for clopidogrel bisulfate, the active ingredient in Plavix, was valid. Reuters

Canada: Patentees Score A Victory In The Supreme Court Of Canada ...  -  Dec 3, 2008
Canada brought pursuant to the Patented Medicines (Notice of Compliance) Regulations, in respect of the blockbuster drug PLAVIX (clopidogrel bisulfate). Mondaq News Alerts (registration),

사노피, '플�?�빅스' 소송서 승리  -  Dec 13, 2008
...하며 FDA�? 플�?�빅스 제네릭 �?산 승�?��?� 신청한 아�?��?스사�? �?�침�?� 가하고 플�?�빅스 주성분�?� 'clopidogrel bisulfate'�? 대한 사노피�?� 특허권�?� �?�정했다. 헬스코리아뉴스,

15/12/08 07:17 Sanofi-Aventis : gagne l'appel dans le procès en ...  -  Dec 14, 2008
...pour le district Sud de New York jugeant le brevet 4.847.265 qui couvre le clopidogrel bisulfate, le principe actif de Plavix, valide et opposable. Challenges,

Ouverture Paris : le CAC40 repart à la hausse  -  Dec 15, 2008
...pour le district Sud de New York jugeant le brevet 4.847.265 qui couvre le clopidogrel bisulfate, le principe actif de Plavix, valide et opposable. Challenges,

Procès Plavix: Sanofi-Aventis et Bristol-Myers gagnent en appel ...  -  Dec 12, 2008
La cour d'appel a confirmé la décision qui jugeait "valide" le brevet protégeant le principe actif du Plavix, le clopidogrel bisulfate, ont indiqué les deux Romandie.com,

Canada: Supreme Court Of Canada Upholds Selection Patents  -  Nov 7, 2008
The selection in this Sanofi case was clopidogrel bisulfate, marketed as Plavix. The invention was the selection of clopidogrel and its bisulfate salt. Mondaq News Alerts (registration),

Rationale and Design of CURRENT-OASIS 7 Study Published in ...  -  Nov 5, 2008
Antiplatelet therapy with Plavix(R) (clopidogrel bisulfate) and aspirin reduces major cardiovascular events in ACS patients during and after coronary MarketWatch

Canadian Supreme Court upholds Sanofi patent for Plavix  -  Nov 11, 2008
...(clopidogrel bisulfate), dealing a blow to the generics maker Apotex, and effectively preventing it from marketing its product in Canada until 2012. Scrip World Pharmaceutical News (subscription),

Rationale and Design of Current-Oasis 7 Study Published in ...  -  Nov 7, 2008
Antiplatelet therapy with Plavix® (clopidogrel bisulfate) and aspirin reduces major cardiovascular events in ACS patients during and after coronary PR-CANADA.net (press release),

Sanofi-Aventis Ups EPS Forecast for 2008 on Slight Improvement in ...  -  Oct 31, 2008
...environment for Sanofi-Aventis since its legal victory in defending the US patent protection for blood-thinner Plavix (clopidogrel bisulfate) last year. PharmaLive.com (press release),

What's New in Adult Reconstructive Knee Surgery  -  Nov 1, 2008
Of 970 consecutive patients, 856 were considered low-risk and were managed with aspirin, dipyridamole, or clopidogrel bisulfate and limb-compression devices Journal of Bone and Joint Surgery (subscription)

Sanofi-aventis : publie le plan de l'étude CURRENT-OASIS 7 (Plavix)  -  Nov 5, 2008
...qui évalue les effets de doses standard et plus élevées de Plavix (clopidogrel bisulfate) et d'aspirine sur les résultats cardiovasculaires et les Challenges,

Novartis/Sanofi: concurrence "limitée" des génériques du Plavix en ...  -  Oct 31, 2008
...français répète régulièrement que le clopidogrel besilate qui compose ces génériques est un sel différent de celui du Plavix (clopidogrel bisulfate). Romandie.com,

Clôture Paris : le CAC40 rechute de 6,3%  -  Nov 6, 2008
...qui évalue les effets de doses standard et plus élevées de Plavix (clopidogrel bisulfate) et d'aspirine sur les résultats cardiovasculaires et les Boursier.com,

Mi-séance Paris : le CAC40 rechute de plus de 4%  -  Nov 6, 2008
...qui évalue les effets de doses standard et plus élevées de Plavix (clopidogrel bisulfate) et d'aspirine sur les résultats cardiovasculaires et les Challenges,

Boehringer Ingelheim Drugs Have No Stroke Advantage  -  Sep 2, 2008
The other study found that Aggrenox (aspirin/dipyridamole) worked no better than Sanofi-Aventis and Bristol-Myers Squibb’s Plavix (clopidogrel bisulfate) in FDA news (subscription),

What's New in Total Hip Arthroplasty  -  Sep 1, 2008
The low-risk group was managed with multimodal prophylaxis, including aspirin, dipyridamole, or clopidogrel bisulfate as well as intermittent calf pneumatic Journal of Bone and Joint Surgery (subscription)

국내 카피약, '비싸다vs싸다' 공방 2�?�운드  -  Aug 18, 2008
...�? 항혈전제 플�?�빅스(성분 clopidogrel bisulfate)정 75mg�?� 우리나�?�는 1206�?, 미국�?� 4335�?으로 3.6배 비싸다. 어린�?�해열제 �?�부프로펜(성분 ibuprofen)시럽�?� Medical Today,

Sanofi-aventis News  -  Jul 31, 2008
...who developed Plavix(R)/Iscover(R) (clopidogrel bisulfate) - should not have been accepted by a regulatory body within the European Union before this PharmaLive.com (press release),

Sanofi-aventis News  -  Jul 31, 2008
...who developed Plavix(R)/Iscover(R) (clopidogrel bisulfate) - should not have been accepted by a regulatory body within the European Union before this PR Newswire (press release),

Portola Raises $60M in Series C Extension  -  Jul 9, 2008
Portola is also developing PRT060128, an antiplatelet agent designed to compete with the blockbuster Plavix (clopidogrel bisulfate, Bristol-Myers Squibb Co. TMCnet

Plavix: concurrents génériques sur le marché allemand pas avant le ...  -  Jul 31, 2008
Selon le groupe français toutefois, le clopidogrel besilate est un sel différent de celui de son anticoagulant Plavix (clopidogrel bisulfate), son deuxième Daily Bourse,

국내 제네릭 �?�약품 가격 미국 제네릭 절반 수준 불과  -  Jul 15, 2008
...�? 항혈전제 플�?�빅스(성분 clopidogrel bisulfate)정 75mg�?� 우리나�?�는 1206�?, 미국�?� 4335�?으로 3.6배 비싸다. 어린�?�해열제 �?�부프로펜(성분 ibuprofen)시럽�?� 마�?��?��?�리,

Plavix: décision d'un tribunal allemand contre Sanofi, qui va ...  -  Jul 29, 2008
Selon le groupe français, le clopidogrel besilate est un sel différent de celui de son anticoagulant Plavix (clopidogrel bisulfate), son deuxième médicament Daily Bourse,

German Regulators Approve Generic Heart Drug  -  Jun 4, 2008
Clopidogrel is a major moneymaker for sanofi and BMS, which market it as Plavix (clopidogrel bisulfate) in the US and Iscover elsewhere. FDA news (subscription),

FDA Action on Prasugrel Delayed Until September  -  Jun 25, 2008
...which compared the drug in 13600 patients with Bristol-Myers Squibb and sanofi-aventis’ blockbuster antiplatelet drug Plavix (clopidogrel bisulfate). FDA news (subscription),

Sanofi takes legal action as generic clopidogrel gets German OK  -  May 29, 2008
However the firm notes that these registrations refer to a different salt of clopidogrel than the one found in Plavix/Iscover (clopidogrel bisulfate) “and Pharma Times (subscription),

Statement on Third-party Clopidogrel Applications in Germany  -  May 28, 2008
These registrations refer to a different salt of clopidogrel than the one of Plavix® (clopidogrel bisulfate), and the products are labelled only for a PharmaLive.com (press release),

UPDATE: Schweizerhall Says It's Near Generic Plavix Launch  -  May 9, 2008
...a generic version of Plavix in the US Dr. Reddy's (RDY) received marketing approval from the US Food & Drug Administration for Clopidogrel Bisulfate. CNNMoney.com

KAI, BMS Join Forces in $227M Heart Drug Deal  -  May 13, 2008
...as Pravachol (pravastatin sodium) and Plavix (clopidogrel bisulfate), "you can't do everything inside the four walls of your company," Daniels said. TMCnet

Generic Plavix opens door for API manufacturers  -  May 13, 2008
...with approval of its generic version of Bristol-Myers Squibb's (BSM) and Sanofi-Aventis' Plavix (clopidogrel bisulfate) in Germany "expected shortly". In-PharmaTechnologist.com,

Sanofi-Aventis Defends Plavix Patent at Canada's Highest Court  -  Apr 16, 2008
Apotex claims that clopidogrel bisulfate, the active ingredient, was covered by a patent that expired in 2003. Sanofi maintains that the earlier patent Bloomberg

Answering Questions On Improvising Musicians, Shyness And Lawyer ...  -  Apr 14, 2008
Question: Should you take Plavix (clopidogrel bisulfate) if you have an ulcer? Answer: No, and that's made clear by the manufacturer, Sanofi-Aventis: "If Evening Bulletin,

Popularity of anti-VEGF therapies sparks debate over when and how ...  -  Apr 17, 2008
Dr. Puliafito: Now, do you think that if you are taking Plavix (clopidogrel bisulfate, Bristol-Myers Squibb/Sanofi Aventis) and you get macular degeneration OSN SuperSite (subscription),

Pre-Thrombolysis Antiplatelet Therapy Enhances Ischemic Stroke ...  -  11 Mar 2008
...and clopidogrel bisulfate monotherapy (1.1%). In patients with prior antiplatelet therapy, 12 (13.5%) developed symptomatic intracerebral hemorrhage. MedPage Today,

New 300mg Loading Dose Tablet for Plavix(R) Receives Positive ...  -  Mar 7, 2008
Evaluation Agency (EMEA) has issued a positive opinion recommending approval of the 300mg tablet of the antiplatelet Plavix(R) (clopidogrel bisulfate). Lifescience-online,

New 300mg Loading Dose Tablet for Plavix(R) Receives Positive ...  -  Mar 5, 2008
Agency (EMEA) has issued a positive opinion recommendingapproval of the 300mg tablet of the antiplatelet Plavix(R)(clopidogrel bisulfate). Juraforum.de,

New 300mg Loading Dose Tablet For Plavix Gets Positive Opinion ...  -  Mar 5, 2008
Medicines Evaluation Agency issued a positive opinion recommending sanction of the 300mg tablet of the antiplatelet Plavix, or clopidogrel bisulfate. RTT News,

Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp ...  -  Feb 12, 2008
Apotex had launched a generic clopidogrel bisulfate in August 2006, following which the US District Court for the Southern District of New York awarded PR Newswire (press release),

Sanofi-Aventis says generic Plavix launch by Dr. Reddy 'highly ...  -  Jan 17, 2008
BY: Dr. Reddy's received marketing approval from the US Food & Drug Administration for Clopidogrel Bisulfate, a generic version of Sanofi's blood-thinning MarketWatch

Sanofi Aventis sees no Plavix copy despite FDA  -  Jan 18, 2008
The US Food and Drug Administration said on Wednesday it had approved pills containing clopidogrel bisulfate, the active ingredient in Plavix, Reuters

Dr. Reddy's Gets FDA Approval to Sell Generic Plavix in US  -  Jan 16, 2008
The US Food and Drug Administration allowed Hyderabad- based Dr. Reddy's to sell tablets of clopidogrel bisulfate, or generic Plavix, the regulator said on Bloomberg

Bristol-Myers Squibb Company Reports Financial Results for the ...  -  Jan 31, 2008
Estimated total US prescription demand for clopidogrel bisulfate (branded and generic) increased by 6% in the fourth quarter of 2007 compared to 2006. CNNMoney.com

Sanofi-aventis Announces a Good Third Quarter Performance ...  -  Oct 31, 2007
Apotex launched a generic clopidogrel bisulfate in August 2006, following which the US District Court for the Southern District of New York awarded sanofi- CNNMoney.com

Higher R&D Costs to Eat Sales Gains for Daiichi Sankyo  -  Nov 5, 2007
The study compared the effects of the drug to Bristol-Myers Squibb’s blockbuster Plavix (clopidogrel bisulfate). The main driver of Daiichi Sankyo’s R&D FDA news (subscription),

Prasugrel Found to Reduce Death Risk But Increase Major Bleeding  -  Nov 12, 2007
...nonfatal heart attacks and nonfatal strokes compared with those taking Bristol-Myers Squibb and sanofi-aventis’ Plavix (clopidogrel bisulfate). FDA news (subscription),

FDA Approves New 300mg Loading Dose Tablet for PLAVIX®  -  Oct 23, 2007
...today that the FDA has approved a supplemental new drug application(snda) for a 300mg tablet of the antiplatelet PLAVIX® (clopidogrel bisulfate). Pharmaceutical Processing,

Bristol-Myers Squibb Company Reports Financial Results for the ...  -  Oct 25, 2007
Estimated total US prescription demand for clopidogrel bisulfate (branded and generic) increased by 7% in the third quarter of 2007 compared to 2006. CNNMoney.com

Sanofi-Aventis Q3 Adj. Profit Up 9.1%; Lifts FY07 Adj. EPS Growth ...  -  Oct 31, 2007
The company noted that the product has been affected since August 8, 2006 by the launch of a generic clopidogrel bisulfate by Apotex. sanofi-aventis was RTT News,

Search By Symbol  -  Oct 25, 2007
The company said that estimated total US prescription demand for clopidogrel bisulfate, branded and generic, increased 7% in the quarter from a year ago, RTT News,

FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R ...  -  Sep 27, 2007
WHO SHOULD RECEIVE Plavix (clopidogrel bisulfate)? -- Recent Myocardial Infarction (MI), Recent Stroke, or Established Peripheral Arterial Disease (PAD) For CNNMoney.com

Plavix 300 mg Tablets Approved  -  Oct 1, 2007
The FDA has approved Sanofi-Aventis’ SNDA for Plavix (clopidogrel bisulfate) 300 mg tablets for use in appropriate acute coronary syndrome (ACS) patients as Facts and Comparisons,

Groups Ask Lawmakers to Support Generic Drug Access  -  Oct 4, 2007
...year when it placed Thailand on the Special 301 Priority Watch List for issuing compulsory licenses for two HIV drugs and Plavix (clopidogrel bisulfate). FDA news (subscription),

US FDA approves new 300 mg loading dose tablet for Plavix(R)  -  Sep 27, 2007
Food and Drug Administration has approved a supplemental new drug application for a 300 mg tablet of the antiplatelet PLAVIX(R)(clopidogrel bisulfate). CNNMoney.com

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.